CRNX - Crinetics Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2018-12-30
2017-12-30
2016-12-30
Cash flows from operating activities
Net Income
-44,368
-27,115
-9,157
-6,019
Depreciation & amortization
866
471
128
92
Deferred income taxes
-
-
-
-
Stock based compensation
5,310
2,320
271
270
Change in working capital
533
5,298
-721
189
Accounts receivable
-
-
-
-
Inventory
-
-
-
-
Accounts Payable
-
-
47
300
Other working capital
-39,689
-20,518
-9,783
-5,658
Other non-cash items
-275
-433
-
-
Net cash provided by operating activites
-38,943
-19,459
-9,479
-5,468
Cash flows from investing activities
Investments in property, plant and equipment
-746
-1,059
-304
-190
Acquisitions, net
-
-
-
-
Purchases of investments
-185,469
-118,399
0
0
Sales/Maturities of investments
-
-
-
-
Other investing activites
-
-
-
-
Net cash used for investing activites
-64,191
-119,458
-304
-190
Cash flows from financing activities
Debt repayment
-
0
-212
-48
Common stock issued
0
106,472
0
0
Common stock repurchased
-
-
-
-5
Dividends Paid
-
-
-
-
Other financing activites
-
-
-
-
Net cash used privided by (used for) financing activities
59
170,198
11,823
-53
Net change in cash
-103,075
31,281
2,040
-5,711
Cash at beginning of period
170,154
14,192
12,152
17,863
Cash at end of period
67,079
45,473
14,192
12,152
Free Cash Flow
Operating Cash Flow
-38,943
-19,459
-9,479
-5,468
Capital Expenditure
-746
-1,059
-304
-190
Free Cash Flow
-39,689
-20,518
-9,783
-5,658